Info

Beta Switch Program

Beta Switch Program

Get Instant Access

77. Dackiw AP, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg. 2001;25:914-26.

78. Icard P, Chapuis Y, Andreassian B, et al. Adrenocortical car cinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992;112:972.

79. Kendrick ML, Lloyd R, Erickson L, et al. Adrenocortical car cinoma: surgical progress or status quo? Arch Surg 2001;136:543-9.

80. Angeli A, Osella G, Ali A, Terzolo M. Adrenal inciden-

taloma: an overview of clinical and epidemiological data from the national Italian study group. Horm Res 1997;47:279.

81. Pommier RF, Brennan MF. An eleven year experience with adrenocortical carcinoma. Surgery 1992;62:963.

82. Proye CAG, Pattou FN. Adrenocortical carcinoma: nonfunc-

tioning and functioning. In: Textbook of endocrine surgery. Philadelphia: WB Saunders; 1997. p. 490-6.

83. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S,

Makowska AM. Adrenocortical carcinoma: a clinical study and treatment results in 52 patients. Cancer 1995;73:2587.

84. Luton JP, Cerdas S, Bricaire H, et al. Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med 1990;322:1195.

85. Haak HR, Hermans J, Krans HM, et al. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994;69:947.

86. Schulick RD, Brennan MF. Long-term survival after com plete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999;6:719.

87. Tikkanen MJ, Sivula A, Kahri A, Pelkonen R. Recurrent adrenal cortical carcinoma with Cushing's syndrome: twenty-five-year follow-up of a patient. J Endocrinol Invest 1980;3:425-7.

88. Kwauk S, Burt M. Pulmonary metastases from adrenal corti cal carcinoma: results of resection. J Surg Oncol 1993;53: 243-6.

89. Doppman JL, Chrousos GP, Papanicolaou DA, et al. Adreno-

corticotropin-independent macronodular adrenal hyper-plasia: an uncommon cause of primary adrenal hypercor-tisolism. Radiology 2000;216:797-802.

90. Swain JM, Grant CS, Schlinkert RT, et al. Corticotropin-

independent macronodular adrenal hyperplasia: a clinico-pathologic correlation. Arch Surg 1998;133:541-5.

91. Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macron-odular disease) leading to Cushing syndrome. Horm Metab Res 1998;30:456-63.

92. Stratakis CA, Carney JA, Lin JP, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996;97:599-607.

93. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type L-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.

94. Samuels MH, Loriaux DL. Cushing's syndrome and nodular adrenal gland. Endocrinol Metab Clin North Am 1994;23: 555-69.

95. Young WF, Carney JA, Musa BU, et al. Familial Cushing's syndrome due to primary pigmented nodular adrenocorti-cal disease. N Engl J Med 1989;321:1659-64.

96. Lacroix A, Tremblay J, Rousseau G, et al. Propranolol ther apy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.

97. Lacroix A, Bolte E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion: a new cause of Cushing's syndrome. N Engl J Med 1992;327: 974-80.

98. de Herder WW, Bonner TI, Bonjer HJ, et al. Food-dependent

Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab 1996;81: 3168-72.

99. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med 1992;327:1033.

100. Fernandez-Cruz L, Saenz A, Benarroch G, et al. Laparo-

scopic unilateral and bilateral adrenalectomy for Cush-ing's syndrome—transperitoneal and retroperitoneal approaches. Ann Surg 1996;6:727-36.

101. Sarkar R, Thompson NW, McLeod MK. The role of adrenalec-

tomy in Cushing's syndrome. Surgery 1990;108:1079-84.

102. McLeod MK. Complications following adrenal surgery. J

Natl Med Assoc 1991;83:161-4.

103. Chapuis Y, Pitre J, Conti F, et al. Role and operative risk of bilateral adrenalectomy in hypercortisolism. World J Surg 1996;20:775-9.

104. Imai T, Funahashi H, Takagi H, et al. Adrenalectomy for treat ment of Cushing syndrome: results in 122 patients and long-term follow-up studies. World J Surg 1996;20:781-6.

105. Favia G, Boscaro M, Lumachi F, D'Amico DF. Role of bilat eral adrenalectomy in Cushing's disease. World J Surg 1994;18:462-6.

106. Go H, Takeda M, Imai T, et al. Laparoscopic adrenalectomy for Cushing's syndrome: comparison with primary aldosteronism. Surgery 1995;117:11-7.

107. Byyny RL. Withdrawal from glucocorticoid therapy. N Engl

J Med 1976;295:30-2.

108. Howlett TA. An assessment of optimal hydrocortisone replace ment therapy. Clin Endocrinol (Oxf) 1997;46:263-8.

109. Pereira MA, Halpern A, Salgado LR, et al. A study of patients with Nelson's syndrome. Clin Endocrinol 1998;49:533-9.

110. Kemink SA, Wesseling P, Pieters GF. Progression of a Nel son's adenoma to pituitary carcinoma: a case report and a review of literature. J Endocrinol Invest 1999;22:70-5.

111. Nagesser SK, van Seters AP, Kievit J, et al. Long-term results of total adrenalectomy for Cushing's disease. World J Surg 2000;24:108-13.

112. Grabner P, Hauer-Jensen M, Jervell J, Flatmark A .Long-term results of treatment of Cushing's disease by adrenalectomy. Eur J Surg 1991;157:461-4.

113. Takumi S, Itoh N, Sato Y, Tsukamoto T. Subclinical Cushing syndrome due to adrenocorticotropic hormone-independent macronodular adreocortical hyperplasia: changes in plasma cortisol levels during long-term follow-up. Urology 2000;55:145x-xii.

114. Morika M, Fujii T, Matsuki T, Kondo K. Preclinical Cush ing's syndrome: report of seven cases and review of literature. Int J Urol 2000;7:126-32.

115. Cheitlin RA, Westphal M, Cabrera CM, et al. Cushing's syn drome due to bilateral macronodular hyperplasia with undetectable ACTH: cell culture of adenoma cells on extra cellular matrix. Horm Res 1988;29:162-7.

116. Hensen J, Oelkers W. Endocrine activity of the silent adrenocortical adenoma is uncovered by response to corticotrophin-releasing hormone. Klin Wochenschr 1990;68:608-14.

117. Mantero F, Arnaldi G. Adrenal incidentaloma: an overview of hormonal data from the national Italian Study Group. Horm Res 1997;47:284-9.

118. Bondanelli M, Campo M, Degli Uberto EC, Pansini R. Eval uation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997;46:107-13.

Was this article helpful?

0 0

Post a comment